Search

everythinglearnresearchcommunity

for

Search:↓

Combination therapy effectively regrows hair and reduces severity in Black children with stubborn Alopecia Areata.

General anesthesia might be linked to certain types of hair loss, but more research is needed.

New medications could improve treatment for severe alopecia areata in Australia.

FCER1A and RGS1 may help diagnose and treat systemic lupus erythematosus.

Certain immune markers and vitamin levels could help diagnose alopecia areata.

Compound glycyrrhizin with conventional treatments is effective and safe for hair regrowth in alopecia areata.

Most patients improved in both atopic dermatitis and alopecia areata with certain treatments, but some had worsened symptoms, suggesting personalized care is needed.

Pediatric alopecia areata is more immune-active than adult cases, suggesting age-specific treatments and potential use of JAK inhibitors.

Hair helps prevent scalp skin cancer by supporting immune protection.

Higher prolactin levels are linked to psoriasis, alopecia areata, and vitiligo severity.

Dupilumab helped an 11-year-old boy regrow hair and reduce skin rashes.

Hair protects the scalp from skin cancer by aiding immune defense.

Activating TLR9 helps heal wounds and regrow hair by using specific immune cells.

Diphenylcyclopropenone is effective and safe for treating severe alopecia areata in children, with maintenance therapy reducing relapse risk.

Th22 cells are essential for Tβ15-induced hair growth in mice.

Adipose stem cell exosomes may effectively treat atopic dermatitis by reducing inflammation and improving skin health.

Nanotechnology could improve hair regrowth but faces challenges like complexity and safety concerns.

Immune cells are essential for skin regeneration using biomaterial scaffolds.

The document explains how the immune system reacts to organ transplants and the treatments used to prevent rejection.

Neutrophils are key in causing chronic itch in atopic dermatitis, and blocking CXCR3 could reduce this itch.

Y27632 increases cell growth through EGFR signaling, not ROCK1/2.

Blocking LFA-1 prevents hair loss in mice.

In 2017, pediatric dermatology advanced with new treatments and insights into various skin conditions in children.

Certain immune molecules and stress affect hair loss, and while genes play a role, more research is needed to fully understand and treat it.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Adipose-derived stem cell secretome is a promising and effective treatment for skin repair.

JAK inhibitors show promise for treating various skin diseases.

Sprout extracts may improve skin and hair health.

Stem cell therapy shows promise for treating skin disorders.

Baricitinib significantly improved hair regrowth and skin condition in a 14-year-old with alopecia areata and atopic dermatitis.